skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

9 Total results for product and free and sample content found

Pink Sheet

Europe’s Ad Hoc Pandemic Response Highlights Supply Chain Weaknesses

europe-ad-hoc

Panelists at a recent virtual session of the DIA’s Europe 2020 conference identified the positive and negative aspects of Europe’s response to the pandemic, and suggested ways of avoiding shortages and making the supply chain more resilient in the event of future crises.

Topic Coronavirus Distribution EU

Pink Sheet

EU Countries Test Offering Simultaneous Scientific Advice

EU_Countries_Test_Offering

An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.

Medtech Insight

Medicinal Products Expert And Established Devices Leader Head Commission's Medtech Unit

Medicinal_Products_Expert_And_Established_Devices

Erik Hansson remains deputy head of devices in a move to the European Commission’s DG Sante from DG Grow. He now answers to a newly appointed devices head who shares a common educational background but whose recent pharmaceutical role may unsettle the devices industry.

Pink Sheet

EU 2019 Approvals: Novel Therapies Make Strong Showing

EU_2019_Approvals_Novel_Therapies

Bluebird bio’s gene therapy Zynteglo, Akcea’s antisense drug Waylivra and BioMarin’s enzyme substitution therapy Palynziq were among the novel innovative medicines that were approved in Europe in 2019. 

HBW Insight

EU Wellness Market In 2019: The CBD Green Rush

EU_Wellness_Market_In_2019_The_CBD_Green_Rush

An interactive timeline of HBW Insight's coverage of the blossoming European CBD market in 2019. The timeline covers the main events of the year beginning with the European Commission's decision to classify CBD as a novel food, and ending on the filing of the first application for a synthetic form of the cannabis-derived ingredient.

Medtech Insight

Official: European Parliament Signs Off Council of EU's 4 Extra Years For Class I Upclassified Devices

Offiical_European_Parliament_Signs_Off

Medtech industry gets best seasonal gift as Council of EU and European Parliament agree on longer transition period for upclassified Class I medical devices. But how many notified bodies are still auditing products under the medical device directives?

Medtech Insight

Has EU Sorted Expert Panels As Tsunami Of 700 Applications Pour In After Extended Deadline?

Article

Only just over a month ago there were fears that the implementation of the EU Medical Device Regulation was going to be hampered by a lack of expert panel applicants. Now it seems there is no shortage. The news raises lots of questions about when and how the structure will now work.

Medtech Insight

Competent Authorities Drive Unilateral Eudamed Delay Decision Onto Council Of EU Agenda

Article

The two-year delay to Eudamed was a Commission decision. Now the competent authorities are fighting back and the issue is to be discussed at the level of the Council of the European Union on December 9 to avoid “heavily burdensome administrative transitional solutions.”

Medtech Insight

Landmark Date Highlights Major Problems In Implementing IVDR As Well As MDR

Article

There may have been a significant increase in the amount of regulatory activity at EU level of late, but the medtech industry remains alarmed at the lack of readiness of the system, and calls for an urgent focus on IVDs now too.

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: